Mirdametinib
Mirdametinib is a potent, bioavailable and selective MEK inhibitor that targets mitogen-activated protein kinase kinase (MAPK/ERK kinase or MEK) with potential anti-tumor activity.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0407 |
| Pricing | 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire |